Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
Senti Bio Reports Second Quarter 2025 Financial Results and Confirms Next Data Milestone for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) Expected Q4 2025
-
Senti Bio to Participate in a Virtual Fireside Chat Hosted by Chardan Capital Markets, LLC
-
Senti Biosciences (SNTI) Strengthens Leadership Team with Strategic Hires
-
Senti Bio Strengthens Leadership Team with Strategic Hires
-
Senti Biosciences, Inc. (SNTI) PT Raised to $12 at Chardan Capital Markets
-
Senti Bio to Participate in Upcoming Investor Conferences
-
Senti Bio to Participate in Upcoming Conferences
-
Senti Bio to Participate in Upcoming Investor Conferences
-
Senti Bio to Participate in Upcoming Investor Conferences
-
UPDATE: Chardan Capital Markets Starts Senti Biosciences, Inc. (SNTI) at Buy, PT $12
-
Senti Bio to Participate in Chardan’s 6th Annual Genetic Medicines Conference
-
Senti Bio to Participate in Chardan’s 6th Annual Genetic Medicines Conference
-
Chardan Announces Launch of ChEF (Chardan Equity Facility)
